[Plasma asymmetric dimethylarginine and cystatin C levels in patients with coronary artery disease].

Abstract

OBJECTIVE To compare plasma asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and cystatin C levels in patients with or without coronary artery disease (CAD). METHODS We recruited 87 CAD patients (39 with acute myocardial infarction and 48 with unstable angina pectoris) and 51 non-CAD controls. Plasma ADMA was measured by… (More)

Topics

  • Presentations referencing similar topics